Optum Ventures and Heritage Provider Network reinvested as the healthcare expertise platform increased its overall funding to $40m with a series C round led by Deerfield Managment.
Month: March 2020
Goodlord gets series B funding
Rocket Internet-backed Goodlord has taken its total funding past $22m having raised more than $12.4m in a round led by venture firm Finch Capital.
AIQ’s aim is true in series B round
Hakuhodo DY subsidiary Spicebox unit and existing backer And Factory were among the investors that provided $10.7m for the social media marketing platform.
Koch disrupts another industry with InSightec
Koch Disruptive Technologies (KDT), a subsidiary of Koch Industries, is living up to its name.
InSightec locks in Koch for $150m series F
The ultrasound surgery system developer is targeting $150m at a $1.3bn post-money valuation, with Koch Disruptive Technologies supplying $100m.
Arkin makes a mark with $140m fund
Phoenix Group and Migdal have supplied capital for Arkin Bio-Ventures II, which investment firm Arkin Holdings will use to invest in 10 to 12 drug developers.
Strive arrives at $100m close
Gree’s corporate venturing arm has closed its third fund having raised more than $100m despite failing to reach its initial target.
Zentalis enters IPO stage
The Pharmaron-backed cancer therapy developer is targeting $100m in an initial public offering preceded by $162m in funding.
Corporates make Creative contribution for $50m fund
Corporate venturing units BCH Ventures and Singha Ventures are among the limited partners for Creative Ventures’ second fund, which is over halfway to its $50m target.
Ayala eyes $50m in initial public offering
Novartis and Harel are among the investors set to exit the cancer therapy developer, which also counts Bristol-Myers Squibb as a shareholder.
Imperial heads to Newtown for $20m fund
Supply chain services provider Imperial Logistics is targeting early-stage logistics with a fund that is being managed by venture firm Newtown Partners.
Sparta Science exercises $16m series B
The Qualcomm-backed musculoskeletal assessment software developer boosted its overall funding to $26m with a round led by GSR Ventures.
Nokia wraps up Elenion acquisition
Fibre optic networking technology developer Elenion Technologies has agreed to be sold after receiving a strategic investment from Koch unit Molex Ventures two years ago.
Looking past consensus for better results
Venture capital gets a well-deserved bad rap for its general lack of diversity.